The cytomegalovirus is found in a wide range of tumour types. By treating the virus it is possible to control the growth and reducing the size of tumours. The virus is found in 70 to75% of the adult population and remains unnoticed until tumours, like cancer, develop in the body. There the virus controls many mechanisms in the cancer cells. Brain tumours, breast cancer, or prostate cancer are some of the forms in which CMV may play a central role. Researchers at the Karolinska Institute have shown for the first time the presence of CMV in these tumours and that tumour growth can be reduced by treating CMV.
Researches from 2013 prove that treatments for CMV may give cancer patients a much better prognosis. The study was conducted with brain tumour patients but may be adapted to a large number of other forms of cancer.
After treating CMV the expected mean survival of patients had grown from 13.5 to 56.4 months. The two-year survival rate increased from 18 to 70% in patients who had received at least six months of treatment, and to 90% if they continued to be treated for CMV in addition to their regular oncological treatment. The researchers believe that some patients could even avoid chemotherapy, at least temporarily.
However, by treating the CMV virus, the researchers have managed to give cancer patients more hope for the future.
In 1810 the Karolinska Institute was founded by King Karl XIII as an "academy for the training of skilled army surgeons". Today, the Karolinska Institute is a modern and one of the leading medical universities in the world. Forty percent of medical academic research in Sweden is performed at the Institute which has the widest range of education in medicine and health science. Their mission is to contribute to the improvement of the human health through research and education. This is a major target of the Biltema Foundation, wherefore we invest in the projects at the Karolinska Institute.
The Institute receives investments from government and external funding. They ensure successful research and give opportunity for even better results in coming years.
Close interaction with clinical practice in all of their 22 departments provide important experience. Karolinska Institute was the first to integrate theory and practice of medical education and research in Sweden. Still it is Sweden’s only purely medical university. Many discoveries made at the Karolinska Institute have been of great significance, such as the pacemaker, the gamma knife, the sedimentation reaction (ESR), the Seldinger technique, and the preparation of chemically pure insulin.